Together, these findings highlight a novel regulatory role for ITGB4 in endothelial cell inflammatory responses and atherosclerosis and identify novel targets for the development of innovative therapies to treat atherosclerosis. The gene discussed is ITGB4; the disease is atherosclerosis.